Endocrinology, Vol 133, 675-682, Copyright © 1993 by Endocrine Society

ARTICLES

Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I-binding protein-3, but not GH receptor gene expression in livers of juvenile rats

H Domene, K Krishnamurthi, R Eshet, I Gilad, Z Laron, I Koch, B Stannard, F Cassorla, CT Roberts Jr and D LeRoith
Diabetes Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

In the adult rat, expression of the liver GH receptor, insulin-like growth factor-I (IGF-I), and IGF-I-binding protein-3 (IGFBP-3) genes has been shown to be under GH control. Additionally, hypophysectomy and GH treatment have a differential effect on the relative abundance of liver IGF-I mRNA variants in adult rats. To further elucidate the time of appearance and the extent of GH control of liver GH receptor, IGF-I, and IGFBP-3 gene expression, we studied the effect of hypophysectomy and GH and IGF-I treatment in juvenile rats. Male Wistar rats were hypophysectomized (Hx) on postnatal day 26 and received twice daily sc injections of saline, recombinant human GH (2.5 U/kg.day), or recombinant human IGF-I (500 micrograms/kg.day) for 7 days. Sham- operated rats received the same treatment. Hx animals also received T4 (20 micrograms/kg.day). In Hx animals, there was a significant reduction in body weight (69.8 +/- 6.6 vs. 100.4 +/- 5.4 g; P < 0.001). GH, but not IGF-I, treatment increased body weight (79.6 +/- 9.6 g after GH vs. 69.8 +/- 6.6 g before GH; P < 0.05). GH treatment partially maintained liver, kidney, and lung weights in Hx animals and increased them in intact animals, whereas IGF-I treatment did so only in the lungs of intact and Hx animals. Serum GH and IGF-I levels were markedly reduced in Hx animals compared with those in intact controls, and GH treatment maintained, albeit partially, circulating IGF-I levels compared with those in saline-treated Hx animals. IGF-I mRNA levels were markedly reduced in Hx liver (25.0 +/- 5.4%; P < 0.001 compared with intact controls). GH treatment for 7 days increased IGF-I mRNA levels by 4.8-fold over the levels in 9-day Hx animals and increased IGF-I mRNA levels by 2.2-fold in control rats. Hypophysectomy decreased exon 2-containing transcripts by 7.0-fold and exon 1-containing transcripts by 4.1-fold. GH treatment, however, affected both exon 1- and exon 2-containing transcripts similarly. Hepatic IGFBP-3 mRNA levels were reduced in Hx (53.2 +/- 1.8%; P < 0.01 compared with intact controls) and IGF-treated Hx animals, but were not decreased in Hx GH- treated animals (100.6 +/- 9.5). No changes in GH receptor or GH- binding protein mRNA levels were caused by Hx, GH, or IGF-I treatment.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				A. Sawczenko, O. Azooz, J. Paraszczuk, M. Idestrom, N. M. Croft, M. O. Savage, A. B. Ballinger, and I. R. Sanderson Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children PNAS, September 13, 2005; 102(37): 13260 - 13265. [Abstract] [Full Text] [PDF]

				F. Tronche, C. Opherk, R. Moriggl, C. Kellendonk, A. Reimann, L. Schwake, H. M. Reichardt, K. Stangl, D. Gau, A. Hoeflich, et al. Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth Genes & Dev., March 1, 2004; 18(5): 492 - 497. [Abstract] [Full Text] [PDF]

				M. E. Wilson Effects of Estradiol and Exogenous Insulin-Like Growth Factor I (IGF-I) on the IGF-I Axis during Growth Hormone Inhibition and Antagonism J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4013 - 4021. [Abstract] [Full Text]

				B. Velasco, L. Cacicedo, J. Escalada, J. Lopez-Fernandez, and F. Sanchez-Franco Growth Hormone Gene Expression and Secretion in Aging Rats Is Age Dependent and Not Age-Associated Weight Increase Related Endocrinology, March 1, 1998; 139(3): 1314 - 1320. [Abstract] [Full Text] [PDF]

				Z. Symon, S. Fuchs, Y. Agmon, O. Weiss, I. Nephesh, R. Moshe, M. Brezis, A. Flyvbjerg, and I. Raz The endogenous insulin-like growth factor system in radiocontrast nephropathy Am J Physiol Renal Physiol, March 1, 1998; 274(3): F490 - F497. [Abstract] [Full Text] [PDF]

				J. Escalada, F. Sanchez-Franco, B. Velasco, and L. Cacicedo Regulation of Growth Hormone (GH) Gene Expression and Secretion During Pregnancy and Lactation in the Rat: Role of Insulin-Like Growth Factor-I, Somatostatin, and GH-Releasing Hormone Endocrinology, August 1, 1997; 138(8): 3435 - 3443. [Abstract] [Full Text] [PDF]

				Z. S. Gucev, Y. Oh, K. M. Kelley, J. I. Labarta, P. Vorwerk, and R. G. Rosenfeld Evidence for Insulin-Like Growth Factor (IGF)-Independent Transcriptional Regulation of IGF Binding Protein-3 by Growth Hormone in SKHEP-1 Human Hepatocarcinoma Cells Endocrinology, April 1, 1997; 138(4): 1464 - 1470. [Abstract] [Full Text] [PDF]

				B. Tonshoff, D. R. Powell, D. Zhao, S. K. Durham, M. E. Coleman, H. M. Domene, W. F. Blum, R. C. Baxter, L. C. Moore, and F. J. Kaskel Decreased Hepatic Insulin-Like Growth Factor (IGF)-I and Increased IGF Binding Protein-1 and -2 Gene Expression in Experimental Uremia Endocrinology, March 1, 1997; 138(3): 938 - 946. [Abstract] [Full Text] [PDF]

				E. Melian, B. Velasco, R. Barrios, and F. Sanchez-Franco Basal and Growth Hormone-Induced Hepatic Messenger Ribonucleic Acid Expression of Insulin-Like Growth Factor-I (IGF-I) and IGF-Binding Protein-3 Is Independent of Hyperinsulinemia and Increased Energy Status in the Genetically Obese Zucker Rat Endocrinology, March 1, 1997; 138(3): 1066 - 1071. [Abstract] [Full Text] [PDF]

				A. Spagnoli, V. Hwa, W. A. Horton, G. P. Lunstrum, C. T. Roberts Jr., F. Chiarelli, M. Torello, and R. G. Rosenfeld Antiproliferative Effects of Insulin-like Growth Factor-binding Protein-3 in Mesenchymal Chondrogenic Cell Line RCJ3.1C5.18. RELATIONSHIP TO DIFFERENTIATION STAGE J. Biol. Chem., February 16, 2001; 276(8): 5533 - 5540. [Abstract] [Full Text] [PDF]